178 related articles for article (PubMed ID: 24289229)
1. Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.
Rezano A; Kuwahara K; Yamamoto-Ibusuki M; Kitabatake M; Moolthiya P; Phimsen S; Suda T; Tone S; Yamamoto Y; Iwase H; Sakaguchi N
BMC Cancer; 2013 Dec; 13():562. PubMed ID: 24289229
[TBL] [Abstract][Full Text] [Related]
2. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.
Gondo N; Sakai Y; Zhang Z; Hato Y; Kuzushima K; Phimsen S; Kawashima Y; Kuroda M; Suzuki M; Okada S; Iwata H; Toyama T; Rezano A; Kuwahara K
Lab Invest; 2021 Aug; 101(8):1048-1059. PubMed ID: 34031538
[TBL] [Abstract][Full Text] [Related]
3. DSS1 is required for the stability of BRCA2.
Li J; Zou C; Bai Y; Wazer DE; Band V; Gao Q
Oncogene; 2006 Feb; 25(8):1186-94. PubMed ID: 16205630
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.
Marston NJ; Richards WJ; Hughes D; Bertwistle D; Marshall CJ; Ashworth A
Mol Cell Biol; 1999 Jul; 19(7):4633-42. PubMed ID: 10373512
[TBL] [Abstract][Full Text] [Related]
5. Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry.
Zhao W; Vaithiyalingam S; San Filippo J; Maranon DG; Jimenez-Sainz J; Fontenay GV; Kwon Y; Leung SG; Lu L; Jensen RB; Chazin WJ; Wiese C; Sung P
Mol Cell; 2015 Jul; 59(2):176-87. PubMed ID: 26145171
[TBL] [Abstract][Full Text] [Related]
6. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
7. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
9. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells.
Gudmundsdottir K; Lord CJ; Witt E; Tutt AN; Ashworth A
EMBO Rep; 2004 Oct; 5(10):989-93. PubMed ID: 15359272
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
Zhang X; Schulz R; Edmunds S; Krüger E; Markert E; Gaedcke J; Cormet-Boyaka E; Ghadimi M; Beissbarth T; Levine AJ; Moll UM; Dobbelstein M
Mol Cell; 2015 Jul; 59(2):243-57. PubMed ID: 26145175
[TBL] [Abstract][Full Text] [Related]
11. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
Liu X; Yao N; Qian J; Huang H
Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810
[TBL] [Abstract][Full Text] [Related]
12. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
13. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death.
Moela P; Choene MM; Motadi LR
Immunobiology; 2014 Aug; 219(8):593-601. PubMed ID: 24703106
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
15. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
[TBL] [Abstract][Full Text] [Related]
16. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
17. PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.
Wang H; He Z; Xia L; Zhang W; Xu L; Yue X; Ru X; Xu Y
Oncol Rep; 2018 Oct; 40(4):2343-2352. PubMed ID: 30066880
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic role of SKIP in human breast carcinoma.
Liu X; Ni Q; Xu J; Sheng C; Wang Q; Chen J; Yang S; Wang H
J Mol Histol; 2014 Apr; 45(2):169-80. PubMed ID: 24150787
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.
Marzec KA; Lin MZ; Martin JL; Baxter RC
Oncotarget; 2015 Sep; 6(29):26583-98. PubMed ID: 26378048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
